Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MIRCERA for Nephrogenic anaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 100 adverse event reports in the FDA FAERS database where MIRCERA was used for Nephrogenic anaemia.

Most Reported Side Effects for MIRCERA

Side Effect Reports % Deaths Hosp.
Death 47 34.6% 47 10
Haemoglobin decreased 14 10.3% 1 2
Anaemia 13 9.6% 0 9
Aplasia pure red cell 13 9.6% 0 6
Disease progression 7 5.2% 7 3
Anti-erythropoietin antibody positive 5 3.7% 0 3
Drug ineffective 5 3.7% 0 4

Other Indications for MIRCERA

Product used for unknown indication (19) Anaemia (12)

Other Drugs Used for Nephrogenic anaemia

DARBEPOETIN ALFA (5,332) METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA (2,331) ARANESP (1,740) DAPRODUSTAT (859) ERYTHROPOIETIN (750) PEGZEREPOETIN ALFA (325) EPOETIN ALFA-EPBX (169) VADADUSTAT (140) ENARODUSTAT (66) ROXADUSTAT (57)

Related Pages

MIRCERA Full Profile All Nephrogenic anaemia Drugs MIRCERA Demographics MIRCERA Timeline